Will caloric restriction and folate protect against AD and PD?
- 25 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 60 (4) , 690-695
- https://doi.org/10.1212/01.wnl.0000042785.02850.11
Abstract
Recent epidemiologic studies of different sample populations have suggested that the risk of AD and PD may be increased in individuals with high-calorie diets and in those with increased homocysteine levels. Dietary restriction and supplementation with folic acid can reduce neuronal damage and improve behavioral outcome in mouse models of AD and PD. Animal studies have shown that the beneficial effects of dietary restriction result, in part, from increased production of neurotrophic factors and cytoprotective protein chaperones in neurons. By keeping homocysteine levels low, folic acid can protect cerebral vessels and can prevent the accumulation of DNA damage in neurons caused by oxidative stress and facilitated by homocysteine. Although further studies are required in humans, the emerging data suggest that high-calorie diets and elevated homocysteine levels may render the brain vulnerable to neurodegenerative disorders.This publication has 48 references indexed in Scilit:
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restrictionTrends in Neurosciences, 2001
- Presenilin mutations and calcium signaling defects in the nervous and immune systemsBioEssays, 2001
- Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stressJournal of Neurochemistry, 2001
- Stem cells and aging: expanding the possibilitiesMechanisms of Ageing and Development, 2001
- Homocysteine and strokeCurrent Opinion in Neurology, 2001
- Neuroprotective Strategies in Parkinson's Disease Using the Models of 6‐Hydroxydopamine and MPTPaAnnals of the New York Academy of Sciences, 2000
- Elevated Plasma Levels of Homocysteine inParkinson’s DiseaseEuropean Neurology, 1998